Tractus Vascular recently announced the first-in-man use of the Tractus Crossing Support Catheter (Tractus CSC). The Tractus CSC represents a highly novel approach to treating vascular disease, the company states.
Chronic total occlusion (CTO) remains one of the most challenging pathologies encountered by surgeons and interventionalists in performing endovascular interventions. John H. Rundback and Kevin Herman of American Endovascular and Amputation Prevention in West Orange, New Jersey, USA both used the Tractus CSC to treat several patients with challenging cases of critical limb ischaemia, including CTO. Rundback noted, “the Tractus catheter tracked like ice and performed exceptionally well; the cases were all extremely successful.”
The Tractus CSC is US Food and Drug Administration (FDA) 510(k) cleared with 0.014inch, 0.018inch and 0.035inch guidewire compatibility and lengths of 90, 135, 155 and 170cm. While most crossing support catheters are constructed with a braided sheath, Tractus offers its Jigsaw Technology laser cut stainless steel shaft consisting of a continuous helical cut pattern forming interlocking teeth. Distal “gusset cuts” offer a continuous stainless steel tip which extends the attributes of this novel catheter shaft.